BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 32319649)

  • 1. High expression of CDCA7 predicts tumor progression and poor prognosis in human colorectal cancer.
    Li S; Huang J; Qin M; Zhang J; Liao C
    Mol Med Rep; 2020 Jul; 22(1):57-66. PubMed ID: 32319649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNA FGD5-AS1 promotes colorectal cancer cell proliferation, migration, and invasion through upregulating CDCA7 via sponging miR-302e.
    Li D; Jiang X; Zhang X; Cao G; Wang D; Chen Z
    In Vitro Cell Dev Biol Anim; 2019 Sep; 55(8):577-585. PubMed ID: 31332696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression of formin-like 3 contributes to metastasis and poor prognosis in colorectal carcinoma.
    Zeng YF; Xiao YS; Lu MZ; Luo XJ; Hu GZ; Deng KY; Wu XM; Xin HB
    Exp Mol Pathol; 2015 Apr; 98(2):260-7. PubMed ID: 25758200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuron navigator 2 overexpression indicates poor prognosis of colorectal cancer and promotes invasion through the SSH1L/cofilin-1 pathway.
    Tan F; Zhu H; Tao Y; Yu N; Pei Q; Liu H; Zhou Y; Xu H; Song X; Li Y; Zhou Z; He X; Zhang X; Pei H
    J Exp Clin Cancer Res; 2015 Oct; 34():117. PubMed ID: 26452645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Annexin A9 promotes invasion and metastasis of colorectal cancer and predicts poor prognosis.
    Yu S; Bian H; Gao X; Gui L
    Int J Mol Med; 2018 Apr; 41(4):2185-2192. PubMed ID: 29393380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FOXM1 expression correlates with tumor invasion and a poor prognosis of colorectal cancer.
    Chu XY; Zhu ZM; Chen LB; Wang JH; Su QS; Yang JR; Lin Y; Xue LJ; Liu XB; Mo XB
    Acta Histochem; 2012 Dec; 114(8):755-62. PubMed ID: 22326401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RacGAP1 expression, increasing tumor malignant potential, as a predictive biomarker for lymph node metastasis and poor prognosis in colorectal cancer.
    Imaoka H; Toiyama Y; Saigusa S; Kawamura M; Kawamoto A; Okugawa Y; Hiro J; Tanaka K; Inoue Y; Mohri Y; Kusunoki M
    Carcinogenesis; 2015 Mar; 36(3):346-54. PubMed ID: 25568185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of long noncoding RNA ZFAS1 predicts poor prognosis and prompts invasion and metastasis in colorectal cancer.
    Wang W; Xing C
    Pathol Res Pract; 2016 Aug; 212(8):690-5. PubMed ID: 27461828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ITGBL1 promotes migration, invasion and predicts a poor prognosis in colorectal cancer.
    Qiu X; Feng JR; Qiu J; Liu L; Xie Y; Zhang YP; Liu J; Zhao Q
    Biomed Pharmacother; 2018 Aug; 104():172-180. PubMed ID: 29772438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of ncRAN, a long non-coding RNA, contributes to colorectal cancer cell migration and invasion and predicts poor overall survival for colorectal cancer patients.
    Qi P; Xu MD; Ni SJ; Shen XH; Wei P; Huang D; Tan C; Sheng WQ; Zhou XY; Du X
    Mol Carcinog; 2015 Sep; 54(9):742-50. PubMed ID: 24519959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DEPTOR expression negatively correlates with mTORC1 activity and tumor progression in colorectal cancer.
    Lai EY; Chen ZG; Zhou X; Fan XR; Wang H; Lai PL; Su YC; Zhang BY; Bai XC; Li YF
    Asian Pac J Cancer Prev; 2014; 15(11):4589-94. PubMed ID: 24969890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased expression of sestrin 2 predicts unfavorable outcome in colorectal cancer.
    Wei JL; Fu ZX; Fang M; Guo JB; Zhao QN; Lu WD; Zhou QY
    Oncol Rep; 2015 Mar; 33(3):1349-57. PubMed ID: 25572852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Significance of miR-1826 as a Novel Prognostic Biomarker in Colorectal Cancer.
    Hu Y; Yi B; He S; Gao L; Liu P; Wang L; Yu J; Wan D; Zhou J; Zhu X; Zhi Q
    Anticancer Agents Med Chem; 2016; 16(9):1109-16. PubMed ID: 25968874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic Value Investigation and Bioinformatics Analysis of miR-31 in Patients with Lymph Node Metastasis of Colorectal Cancer.
    Zhang WW; Ming XL; Rong Y; Huang CQ; Weng H; Chen H; Bian JM; Wang FB
    Anal Cell Pathol (Amst); 2019; 2019():9740475. PubMed ID: 31934534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High expression of Rab3D predicts poor prognosis and associates with tumor progression in colorectal cancer.
    Luo Y; Ye GY; Qin SL; Mu YF; Zhang L; Qi Y; Qiu YE; Yu MH; Zhong M
    Int J Biochem Cell Biol; 2016 Jun; 75():53-62. PubMed ID: 27046094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KRT18 is correlated with the malignant status and acts as an oncogene in colorectal cancer.
    Zhang J; Hu S; Li Y
    Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31345960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of LDOC1 on colorectal cancer cells via downregulation of the Wnt/β-catenin signaling pathway.
    Jiang J; Li Y; Jiang Z
    Oncol Rep; 2019 Jun; 41(6):3281-3291. PubMed ID: 31002361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GPR48, a poor prognostic factor, promotes tumor metastasis and activates β-catenin/TCF signaling in colorectal cancer.
    Wu J; Xie N; Xie K; Zeng J; Cheng L; Lei Y; Liu Y; Song L; Dong D; Chen Y; Zeng R; Nice EC; Huang C; Wei Y
    Carcinogenesis; 2013 Dec; 34(12):2861-9. PubMed ID: 23803691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Up-regulation of miR-592 correlates with tumor progression and poor prognosis in patients with colorectal cancer.
    Liu M; Zhi Q; Wang W; Zhang Q; Fang T; Ma Q
    Biomed Pharmacother; 2015 Feb; 69():214-20. PubMed ID: 25661360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulated CNTN1 is associated with lymph node metastasis and poor prognosis of colorectal cancer.
    Li G; Zhang Z; Ge G; Fang K; Zhu J
    Cancer Biomark; 2021; 30(2):193-201. PubMed ID: 33104020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.